Grindeks opens API plant in Latvia
June 30, 2011Manufacturing and Production Grindeks, pharma manufacturing news
Latvian pharmaceutical company Grindeks has opened a new active pharmaceutical ingredient (API) manufacturing plant that it predicts will add around …
Tarceva fails to win NICE backing
June 30, 2011Sales and Marketing NICE, Tarceva
NICE has decided not to recommend Roche’s Tarceva because of uncertainty over how long the lung cancer drug can extend …
GSK welcomes outside researchers to its ‘open lab’
June 29, 2011Research and Development GSK, TB, academic alliance, malaria, open lab
The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …
Janssen to collaborate with Jubilant on neuroscience targets
June 29, 2011Manufacturing and Production, Research and Development Janssen, Jubilant, neuroscience research
Janssen is to team up with Indian pharma services company Jubilant Life Sciences on neuroscience drug discovery. Jubilant Discovery Services …
New medicine approvals slumped to record low in 2010
June 29, 2011Research and Development, Sales and Marketing drug sales, new drug approvals, research
There was a major slide in medicine approvals last year, compounding a difficult and ominous period for the industry. Only …
Introducing SHL Pharma: A Greener Approach
June 29, 2011Manufacturing and Production auto injector, autoinjector, automation, final assembly, final packaging
SHL Group is proud to introduce SHL Pharma, a facility built with a greener approach providing final assembly, labeling and …
Treatment flexibility will improve adherence in diabetes, study suggests
June 29, 2011Research and Development, Sales and Marketing diabetes, insulin
A third of patients with diabetes admit to regularly missing or not taking insulin treatment three days a month, according …
Greek debt hits pharma deliveries
June 29, 2011Sales and Marketing Greece
The debt crisis afflicting Greece is starting to affect the country’s hospitals as pharma companies refuse to deliver drugs. Roche …
Regulators back Novartis’ Votubia
June 28, 2011Sales and Marketing Novartis, Votubia, everolimus
Novartis’ drug Votubia has been recommended by regulators to treat a disease for which the only current option in Europe …
BMA warns of ‘slash and burn’ health service cuts
June 28, 2011BMA, NHS reforms
The BMA has hit out against reckless cuts to health service budgets and a ‘phoney war’ on NHS pensions. In …
Shire gets green light for second Replagal facility
June 28, 2011Manufacturing and Production Replagal, Shire, Vpriv, pharma manufacturing news
The European Medicines Agency has approved a second manufacturing facility in the USA for Shire’s Fabry disease treatment Replagal. Shire’s …
GlaxoSmithKline fined $41m for manufacturing failings
June 28, 2011Manufacturing and Production GSK, pharma manufacturing news
GlaxoSmithKline has agreed to pay almost $41 million to dozens of US states in a lawsuit focusing on alleged substandard …
Pharma manufacturing news in brief
June 28, 2011Manufacturing and Production pharma manufacturing news
Abbott delays closure of Canadian facility, West Pharma starts a new build in China, plus updates from Vetter, Pharmadule and …
Sanofi appoints Peter Guenter senior VP, Europe
June 28, 2011Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing
Sanofi has promoted Peter Guenter to senior vice president, Europe, with effect from 15 July. He is currently general manager …
Service Insight: Submission development and market access
June 28, 2011Sales and Marketing Service Insight
SERVICE INSIGHT A successful health technology assessment is critical for market access in the UK. However, submissions that don’t follow …
Pfizer sells Irish manufacturing facility to BioMarin
June 27, 2011Manufacturing and Production BioMarin, Ireland, Pfizer, pharma manufacturing news
Pfizer is selling its Irish manufacturing facility in Shanbally, Cork, to US biopharmaceutical company BioMarin for $48.5 million, creating up …
Activaero appoints Christian Pangratz
June 27, 2011Sales and Marketing appointment, sales and marketing
Activaero GmbH has appointed Christian Pangratz as chief business officer, with a brief to lead its business development, marketing and …
CHMP backs Boehringer-Lilly diabetes drug Trajenta
June 27, 2011Sales and Marketing Tradjenta, Trajenta, diabetes
Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been recommended for European approval. It was given …
Bury the NHS reform bill, says BMJ
June 27, 2011Health and Social Care Bill, NHS reforms
The influential British Medical Journal has called on the government to abandon its healthcare reform bill, which it says has …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
